Article Information
History
- June 1, 2021.
Article Versions
- You are currently viewing Version 1 of this article (June 1, 2021 - 13:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Katie R. Mollan, MS1,2,3,#,
- Joseph J. Eron, MD1,2,3,
- Taylor J. Krajewski, MA1,3,
- Wendy Painter, MD4,
- Elizabeth R. Duke, MD5,
- Caryn G. Morse, MD6,
- Erin A. Goecker, MS7,
- Lakshmanane Premkumar, PhD2,
- Cameron R. Wolfe, MBBS8,
- Laura J. Szewczyk, BS4,
- Paul L. Alabanza, BS3,
- Amy James Loftis, BSc2,
- Emily J. Degli-Angeli, BS7,
- Ariane J. Brown, BS1,
- Joan A. Dragavon, MLM7,
- John J. Won, BS1,
- Jessica Keys, PhD3,
- Michael G. Hudgens, PhD,
- David A. Wohl, MD1,3,
- Myron S. Cohen, MD,
- Ralph S. Baric, PhD1,
- Robert W. Coombs, MD7,
- Timothy P. Sheahan, PhD1,* and
- William A. Fischer II, MD2,9,*,#
- 1Gillings School of Global Public Health, University of North Carolina at Chapel Hill, NC 27599
- 2School of Medicine, University of North Carolina at Chapel Hill, NC
- 3Center for AIDS Research, University of North Carolina at Chapel Hill, NC 27599
- 4Ridgeback Biotherapeutics LP, Miami, Florida 33133
- 5Fred Hutchinson Cancer Research Center, Seattle, WA 98109
- 6Wake Forest School of Medicine, Winston-Salem, NC 27157
- 7Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104
- 8Duke University Medical Center, Durham, NC 27710
- 9Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, NC 27599
- ↵#Corresponding authors:
Mrs. Katie R. Mollan: 3126 McGavran-Greenberg Hall, CB#7420, Chapel Hill, NC 27599 Email: kmollan{at}unc.edu, Phone: 919-966-8421, Dr. William A. Fischer II: 130 Mason Farm Road, CB#7020, Chapel Hill, NC 27599 Email: william_fischer{at}med.unc.edu, Phone: 919-843-9108
Author contributions: KRM, JJE, TPS, and WAF led the conceptualization of the analysis and the writing of original manuscript draft. EAG, LP, EJDA, AJB, JAD, JJW, RSB, RWC, and TPS conducted laboratory assessments of SARS-CoV-2. KRM, TJK, JK, and MGH conducted the data carpentry or statistical analyses. Study data were verified by KRM, TJK, WP, LJS, and WAF. KRM, JJE, WP, LJS, RSB, MGH, DAW, RSB, TPS, and WAF contributed to the study design. WP, ERD, CGM, CRW, LJS, PLA, AJL, and WAF oversaw data collection or protocol implementation. All authors reviewed the draft manuscript and approved the final version.
Posted June 01, 2021.
SARS-CoV-2 infectious virus, viral RNA in nasopharyngeal swabs, and serostatus of symptomatic COVID-19 outpatients in the United States
